Skip to search formSkip to main contentSkip to account menu

AV-203

Known as: Anti-ErbB3 MoAb AV-203, Anti-ErbB3 Monoclonal Antibody AV-203 
A humanized monoclonal antibody (MoAb) directed against the human receptor tyrosine-protein kinase ErbB-3 (HER3) with potential antineoplastic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Targeted therapies have changed the treatment paradigm of cancer. Specifically, the use of tyrosine kinase inhibitors (TKIs) has… 
2012
2012
본 발명은, ErbB3에 결합되는 항체 및 이의 사용 방법을 제공한다. 본 발명의 소정 실시형태에 따르면, 상기 항체는, 사람 ErbB3에 결합되는 완전 사람 항체이다. 소정 실시형태에서, 본 발명의 항체는 ErbB3과 ErbB3… 
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL ERBB3 is widely expressed in human carcinomas, and… 
2010
2010
EGF-like growth factors activate their ErbB receptors by promoting receptor-mediated homodimerisation, or alternatively by the… 
2005
2005
Die Rezeptor-Tyrosin-Kinasen (RTK) der erbB-Familie (EGFR, c-erbB2 bzw. HER2/neu, c-erbB3 und c-erbB4) spielen in der Tumorgenese…